Literature DB >> 19355907

Cytokines in systemic lupus erythematosus.

Elaine V Lourenço1, Antonio La Cava.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies that can form immune complexes and deposit in tissues, causing inflammation and organ damage. There is evidence that interferons and some interleukins can have an active role in the pathogenesis of SLE and can contribute significantly to the immune imbalance in the disease, whereas the role of some cytokines (such as TNF) is still debated. This review discusses the activity of several cytokines in SLE, their effects on the immune cells in relation to the disease pathogenesis, and the promise and limitations of cytokine-based therapies in clinical trials for lupus patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19355907      PMCID: PMC3589140          DOI: 10.2174/156652409787847263

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  236 in total

1.  Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.

Authors:  Bevra H Hahn; Ram Pyare Singh; Antonio La Cava; Fanny M Ebling
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 2.  Musculoskeletal manifestations and autoimmune diseases related to new biologic agents.

Authors:  Boulos Haraoui; Edward Keystone
Journal:  Curr Opin Rheumatol       Date:  2006-01       Impact factor: 5.006

3.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

4.  Transforming growth factor-beta induces development of the T(H)17 lineage.

Authors:  Paul R Mangan; Laurie E Harrington; Darrell B O'Quinn; Whitney S Helms; Daniel C Bullard; Charles O Elson; Robin D Hatton; Sharon M Wahl; Trenton R Schoeb; Casey T Weaver
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

5.  Global natural regulatory T cell depletion in active systemic lupus erythematosus.

Authors:  Makoto Miyara; Zahir Amoura; Christophe Parizot; Cécile Badoual; Karim Dorgham; Salim Trad; Dominique Nochy; Patrice Debré; Jean-Charles Piette; Guy Gorochov
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

6.  Toll-like receptor-7 modulates immune complex glomerulonephritis.

Authors:  Rahul D Pawar; Prashant S Patole; Daniel Zecher; Stephan Segerer; Matthias Kretzler; Detlef Schlöndorff; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2005-11-09       Impact factor: 10.121

Review 7.  Regulatory T cells in lupus.

Authors:  Hee-Kap Kang; Syamal K Datta
Journal:  Int Rev Immunol       Date:  2006 Jan-Apr       Impact factor: 5.311

8.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

9.  Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8.

Authors:  Jörg Vollmer; Sibylle Tluk; Claudia Schmitz; Svetlana Hamm; Marion Jurk; Alexandra Forsbach; Shizuo Akira; Kindra M Kelly; Westley H Reeves; Stefan Bauer; Arthur M Krieg
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

10.  RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

Authors:  Christina M Lau; Courtney Broughton; Abigail S Tabor; Shizuo Akira; Richard A Flavell; Mark J Mamula; Sean R Christensen; Mark J Shlomchik; Gregory A Viglianti; Ian R Rifkin; Ann Marshak-Rothstein
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

View more
  36 in total

1.  Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.

Authors:  Elaine V Lourenço; Claudio Procaccini; Francesca Ferrera; Noriko Iikuni; Ram P Singh; Gilberto Filaci; Giuseppe Matarese; Fu-Dong Shi; Ernest Brahn; Bevra H Hahn; Antonio La Cava
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

2.  Interaction of two phagocytic host defense systems: Fcγ receptors and complement receptor 3.

Authors:  Zhen-Yu Huang; Sharon Hunter; Paul Chien; Moo-Kyung Kim; Tae-Hee Han-Kim; Zena K Indik; Alan D Schreiber
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

Review 3.  Epigenetic mechanisms in lupus.

Authors:  Dipak R Patel; Bruce C Richardson
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

4.  Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Nipith Charoenngam; Ben Ponvilawan; Wasit Wongtrakul; Patompong Ungprasert
Journal:  Clin Rheumatol       Date:  2020-07-07       Impact factor: 2.980

Review 5.  Dendritic cells in systemic lupus erythematosus.

Authors:  Heather M Seitz; Glenn K Matsushima
Journal:  Int Rev Immunol       Date:  2010-04       Impact factor: 5.311

6.  Increased expression of human T-cell immunoglobulin- and mucin-domain-containing molecule-4 in peripheral blood mononuclear cells from patients with system lupus erythematosus.

Authors:  Peiqing Zhao; Liyun Xu; Piming Wang; Xiaohong Liang; Jianni Qi; Peng Liu; Chun Guo; Lining Zhang; Chunhong Ma; Lifen Gao
Journal:  Cell Mol Immunol       Date:  2010-02-08       Impact factor: 11.530

7.  Expression of Toll‑like receptors 3 and 9 in Egyptian systemic lupus erythematosus patients.

Authors:  A S Nasr; S M Fawzy; T A Gheita; E El-Khateeb
Journal:  Z Rheumatol       Date:  2016-06       Impact factor: 1.372

Review 8.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 9.  Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus.

Authors:  E Kassi; P Moutsatsou
Journal:  J Biomed Biotechnol       Date:  2010-06-10

10.  Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.

Authors:  C K Wong; P T Y Wong; L S Tam; E K Li; D P Chen; C W K Lam
Journal:  Clin Exp Immunol       Date:  2009-10-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.